Prestige Consumer Healthcare (PBH) Net Cash Flow (QoQ) (2010 - 2025)
Prestige Consumer Healthcare (PBH) Net Cash Flow (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.42 Bn | 2.36 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -179.55% |
| Sep 30, 2025 | -149.99% |
| Jun 30, 2025 | -12.99% |
| Mar 31, 2025 | 3,224.89% |
| Dec 31, 2024 | -91.49% |
| Sep 30, 2024 | 228.71% |
| Jun 30, 2024 | 22.16% |
| Mar 31, 2024 | -875.48% |
| Dec 31, 2023 | -64.31% |
| Sep 30, 2023 | 258.58% |
| Jun 30, 2023 | 86.47% |
| Mar 31, 2023 | -164.63% |
| Dec 31, 2022 | 498.20% |
| Sep 30, 2022 | -26.64% |
| Jun 30, 2022 | 71.84% |
| Mar 31, 2022 | 126.51% |
| Dec 31, 2021 | 82.02% |
| Sep 30, 2021 | -191.12% |
| Jun 30, 2021 | 545.94% |
| Mar 31, 2021 | -185.67% |